RN0361

· Ikaria Bioscience Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RN0361, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects [Phase 1, Phase 2]